259 results on '"Takamatsu, M."'
Search Results
2. ASSOCIATION OF A TUMOR NECROSIS FACTOR β GENE POLYMORPHISM WITH SUSCEPTIBILITY TO ALCOHOLIC HEPATITIS
- Author
-
Takamatsu, M., Yamauchi, M., Saito, S., Maeyama, S., Uchikoshi, T., and Toda, G.
- Published
- 2000
3. The optimum colour temperature for illumination of Japanese-style gardens in summer and winter.
- Author
-
Jia, D., Misawa, T., Takamatsu, M., and Hirobayashi, S.
- Subjects
COLOR temperature ,GARDEN lighting ,LIGHT sources ,JAPANESE gardens ,IMAGE recognition (Computer vision) - Abstract
Japanese-style gardens offer a wealth of spiritual and cultural value. In this study, we attempt to determine the optimum colour temperature for lighting Japanese-style gardens at night. We analyse the influence of a change in light source colour temperature on image recognition using digitalization and quantification with the semantic differential technique. In addition, we propose a new evaluation methodology for the semantic differential technique and examine the statistical significance of the results. We find that in summer, impressions of the optimum colour temperature for each element (vegetation, water, stone and structure) differ significantly, but in winter, because of the effects of snow, differences in the impression of each colour temperature are not as distinct. Moreover, the colour of the natural environment or overall season affects peoples' preferred light source colour temperature. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
4. Evaluating cataractous color sensitivity in HSV color system.
- Author
-
Fujita, T., Nakashima, Y., and Takamatsu, M.
- Published
- 2009
- Full Text
- View/download PDF
5. Obstructive jaundice caused by a portal cavernoma.
- Author
-
Takamatsu M, Furutake M, Hisa T, Ueda M, Takamatsu, Masato, Furutake, Masayuki, Hisa, Takeshi, and Ueda, Mizuho
- Abstract
A 69-year-old Japanese man was admitted to our hospital because of acute cholangitis with biliary obstruction. The cause of obstruction was either compression by a portal cavernoma or cavernous transformation. Multidetector row computed tomography (MDCT) and abdominal ultrasonography (US) revealed a portal cavernoma around the common bile duct. Magnetic resonance cholangiopancreatography (MRCP) and endoscopic retrograde cholangiography (ERC) demonstrated characteristic short, smooth narrowing of the bile duct. Endoscopic US and intraductal US demonstrated collateral vessels around the bile duct and were helpful for ruling out a neoplastic lesion. Thus, a combination of imaging modalities was useful for diagnosing this hepatobiliary complication, portal biliopathy. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
6. Solubilization and characterization of ileal receptor for intrinsic factor-vitamin b12 complex
- Author
-
Okuda, K., Fujii, T., and Takamatsu, M.
- Published
- 1971
- Full Text
- View/download PDF
7. STAT3 polymorphism predicts interferon-alfa response in patients with metastatic renal cell carcinoma.
- Author
-
Ito N, Eto M, Nakamura E, Takahashi A, Tsukamoto T, Toma H, Nakazawa H, Hirao Y, Uemura H, Kagawa S, Kanayama H, Nose Y, Kinukawa N, Nakamura T, Jinnai N, Seki T, Takamatsu M, Masui Y, Naito S, and Ogawa O
- Published
- 2007
8. Mucoepidermoid carcinoma of the thyroid gland.
- Author
-
Katoh, Ryohei, Sugai, Tamotsu, Ono, Sadahide, Takayama, Kazuo, Tomichi, Nobukazu, Kurihara, Hideo, Takamatsu, Masayuki, Katoh, R, Sugai, T, Ono, S, Takayama, K, Tomichi, N, Kurihara, H, and Takamatsu, M
- Published
- 1990
- Full Text
- View/download PDF
9. Platelet-activating factor acetylhydrolase activity in red blood cell-stroma from patients with cerebral thrombosis.
- Author
-
Yoshida, H., Satoh, K., Imaizumi, T., Takamatsu, S., Hiramoto, M., Shoji, B., and Takamatsu, M.
- Published
- 1992
- Full Text
- View/download PDF
10. A field experiment on power line stabilization by a SMES system.
- Author
-
Irie, F., Takeo, M., Sato, S., Katahira, O., Fukui, F., Okada, H., Ezaki, T., Ogawa, K., Koba, H., Takamatsu, M., and Shimojo, T.
- Published
- 1992
- Full Text
- View/download PDF
11. Inactivation of Vitamin B12 by a Binder in Rat Intestine and the Role of Intrinsic Factor.
- Author
-
Okuda, K., Kitazaki, T., and Takamatsu, M.
- Published
- 1971
- Full Text
- View/download PDF
12. FERMENTWIRKUNG IM VOGELORGANISMUS BEI B-AVITAMINOSE.
- Author
-
TSUNOO, S., TAKAMATSU, M., KAMACHI, T., and IMAIZUMI, M.
- Published
- 1935
13. Pars plana vitrectomy for traumatic cyclodialysis with persistent hypotony.
- Author
-
Ishida, Y., Minamoto, A., Takamatsu, M., Kuwabara, R., Yamane, K., and Mishima, H. K.
- Subjects
LETTERS to the editor ,CYCLODIALYSIS - Abstract
Presents a letter to the editor in response to the article "Pars Pana Vitrectomy for Traumatic Cyclodialysis With Persistent Hypotony," that was previously published in the journal "Eye."
- Published
- 2004
- Full Text
- View/download PDF
14. Mechanisms of Alcoholic Liver Disease: Cytokines.
- Author
-
Neuman, Manuela G., Brenner, D. A., Rehermann, B., Taieb, J., Chollet-Martin, S., Cohard, M., Garaud, J. J., Poynard, T., Katz, G. G., Cameron, R. G., Shear, N. H., Gao, B., Takamatsu, M., Yamauchi, M., Ohata, M., Saito, S., Maeyama, S., Uchikoshi, T., Toda, G., and Kumagi, T.
- Abstract
This article represents the proceedings of a workshop at the 2000 ISBRA Meeting in Yokohama, Japan. The chair was Manuela G. Neuman. The presentations were (1) New aspects of hepatic fibrosis, by D. A. Brenner; (2) Cellular immune response in hepatitis C models, by B. Rehermann; (3) The role of interleukin-10 in acute alcoholic hepatitis, by J. Taieb, S. Chollet-Martin, M. Cohard, J. J. Garaud, and T. Poynard; (4) Cytokine-mediated apoptosis in vitro, by M. G. Neuman; (5) Signaling for apoptosis and repair in vitro, by G. G. Katz, R. G. Cameron, N. H. Shear, and M. G. Neuman; (6) Interferons activate the P42/44 mitogen-activated protein kinase and Janus Kinase signal transducers and activation of transcription (JAK-STAT) signaling pathways in hepatocytes: Differential regulation by acute ethanol via a protein kinase C-dependent mechanism, by B. Gao; (7) Genetic polymorphisms of interleukin-1 in association with the development of Japanese alcoholic liver disease, by M. Takamatsu, M. Yamauchi, M. Ohata, S. Saito, S. Maeyama, T. Uchikoshi, and G. Toda; and (8) Increased levels of macrophage migration inhibitory factor in sera from patients with alcoholic liver diseases, by T. Kumagi, S. M. F. Akbar, M. Abe, K. Michitaka, N. Horiike, and M. Onji. [ABSTRACT FROM AUTHOR]
- Published
- 2001
- Full Text
- View/download PDF
15. Emphysematous Cholecystitis After Endoscopic Wallstent Placement Complicated by Distal Migration of the Stent.
- Author
-
Takasaki, M., Morita, S., Horimi, T., Takamatsu, M., Kawakami, M., and Yorimitsu, Y.
- Published
- 1995
- Full Text
- View/download PDF
16. Psychophysical evaluation of color rendering effect for landscape lighting in a snowy region.
- Author
-
Zhang Ming, Nakashima, Y., Takamatsu, M., Xu Fang, Sawa, K., and ujita, T.F.
- Published
- 2009
- Full Text
- View/download PDF
17. Should we use psychostimulant drugs to boost the emergence from general anesthesia?
- Author
-
Petrenko AB, Takamatsu M, and Baba H
- Published
- 2012
- Full Text
- View/download PDF
18. Effect of annealing sequences on the structure of buried oxide layer in low-dose SIMOX.
- Author
-
Sudou, M., Kainuma, M., Arai, K., Takamatsu, M., Nakai, T., Shingyouji, T., and Cordts, B.
- Published
- 1996
- Full Text
- View/download PDF
19. Hepatitis G virus infection in Japanese patients with chronic liver disease.
- Author
-
Shimoda, Atsushi, Kaneko, Shuichi, Takamatsu, Miho, Kobayashi, Kenichi, Saitou, Tsuyoshi, Kakinuma, Kenichi, Shimoda, A, Kaneko, S, Takamatsu, M, Kobayashi, K, Saitou, T, and Kakinuma, K
- Published
- 1997
- Full Text
- View/download PDF
20. ChemInform Abstract: Synthesis of Antimicrobial Agents. Part 1. Syntheses and Antibacterial Activities of 7-Azole Substituted Quinolones.
- Author
-
UNO, T., TAKAMATSU, M., INOUE, Y., KAWAHATA, Y., IUCHI, K., and TSUKAMOTO, G.
- Published
- 1988
- Full Text
- View/download PDF
21. Selective area PZT-preparation by sol-gel method.
- Author
-
Omori, T., Makita, H., Takamatsu, M., Hashimoto, K., and Yamaguchi, M.
- Published
- 1999
- Full Text
- View/download PDF
22. Experimental study of SMES system with DC intertie for power line stabilization.
- Author
-
Okada, H., Ezaki, T., Ogawa, K., Koba, H., Takeo, M., Funaki, K., Sato, S., Irie, F., Chikaba, J., Terazono, K., Takamatsu, M., Kawakami, M., and Hirano, M.
- Published
- 1988
- Full Text
- View/download PDF
23. Precursor of cdk5 activator, the 23 kDa subunit of tau protein kinase II: Its sequence and developmental change in brain
- Author
-
Uchida, T., Ishiguro, K., Ohnuma, J., Takamatsu, M., Yonekura, S., and Imahori, K.
- Published
- 1994
- Full Text
- View/download PDF
24. Surveys of workers occupationally exposed to PCBs and of Yusho patients
- Author
-
Inoue, Y., Maeda, K., Yoshuzuka, K., Takamatsu, M., Oki, M., and Hirayama, H.
- Subjects
POLYCHLORINATED biphenyls ,THRESHOLD limit values (Industrial toxicology) - Published
- 1985
25. ChemInform Abstract: Hyrtiosins A (I) and B (II), New Indole Alkaloids from the Okinawan Marine Sponge Hyrtios erecta.
- Author
-
KOBAYASHI, J., MURAYAMA, T., ISHIBASHI, M., KOSUGE, S., TAKAMATSU, M., OHIZUMI, Y., KOBAYASHI, H., OHTA, T., NOZOE, S., and SASAKI, T.
- Published
- 1991
- Full Text
- View/download PDF
26. 511 Tau protein kinases and phosphorylated tau protein in human brain
- Author
-
Ishiguro, K., Park, J., Takamatsu, M., Yonekura, S., Sahara, N., Mori, H., Uchida, T., and Imahori, K.
- Published
- 1996
- Full Text
- View/download PDF
27. Significance of an activator of neuronal cyclin dependent kinase 5 in developmental change of tau phosphorylation that is also observed in alzheimer's disease brain
- Author
-
Ishiguro, K., Ohnuma, J., Takamatsu, M., Yonekura, S., Imahori, K., and Uchida, T.
- Published
- 1994
- Full Text
- View/download PDF
28. 1412 Title: Ocular hypotensive effects of PhCA41 in glaucoma patients and IOP change during day and night in normal volunteers
- Author
-
Mishima, H.K., Takamatsu, M., Hirota, A., and Kiuchi, Y.
- Published
- 1995
- Full Text
- View/download PDF
29. Caveolin-1 expression is a predictor of survival and recurrence patterns in resected pancreatic ductal adenocarcinoma.
- Author
-
Hirose Y, Oba A, Takamatsu M, Hamada T, Takeda T, Suzuki T, Maekawa A, Kitano Y, Sato S, Kobayashi K, Omiya K, Ono Y, Sato T, Ito H, Sasaki T, Ozaka M, Takeuchi K, Sasahira N, Inoue Y, Wakai T, and Takahashi Y
- Abstract
Background/objective: Caveolin-1 (Cav1) expressed in cancer cells (cCav1) or cancer-associated fibroblasts (fCav1) exerts either pro- or anti-tumorigenic effects depending on the cancer type or stage of cancer. We aimed to clarify the impact of cCav1 or fCav1 on survival, recurrence patterns, and efficacy of neoadjuvant chemotherapy (NAC) in resected pancreatic ductal adenocarcinoma (PDAC)., Methods: Tissue microarrays were constructed including 615 patients who underwent curative resection for PDAC. Cav1 expression was evaluated by immunohistochemistry. Patients were divided into two groups based on Cav1 expression in cancer cells (cCav1
high vs. cCav1low ) or cancer-associated fibroblasts (fCav1high vs. fCav1low )., Results: Among all 615 patients, 40.7% were cCav1high and 72.7% were fCav1high . cCav1high was associated with worse overall survival (OS) (p = 0.001) and recurrence-free survival (RFS) (p = 0.001) than cCav1low , and was an independent prognostic factor in multivariate analysis of OS and RFS (OS: p = 0.001, hazard ratio [HR] 1.361; RFS: p = 0.001, HR 1.348). Among 596 patients with resectable/borderline resectable PDAC, cCav1high patients with NAC showed better OS than those without, while there was no significant difference between cCav1low patients with NAC and those without. cCav1high was associated with early recurrence (< 6 months) and liver metastasis after resection. Multivariate analysis revealed cCav1high as an independent predictor of liver metastasis., Conclusions: cCav1high correlated with worse survival, early recurrence, and liver metastasis after resection for PDAC, while NAC improved survival in cCav1high patients. The Evaluation of cCav1 status could provide additional information contributing to the personalized management of PDAC., (Copyright © 2024 IAP and EPC. Published by Elsevier B.V. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF
30. Treatment Decision for Locally Resected T1 Colorectal Carcinoma-Verification of the Japanese Guideline Criteria for Additional Surgery Based on Long-Term Clinical Outcomes.
- Author
-
Oka S, Tanaka S, Kajiwara Y, Saito S, Fukunaga Y, Takamatsu M, Kawachi H, Hotta K, Ikematsu H, Kojima M, Saito Y, Yamada M, Kanemitsu Y, Sekine S, Nagata S, Yamada K, Kobayashi N, Ishihara S, Saitoh Y, Matsuda K, Togashi K, Komori K, Ishiguro M, Kuwai T, Okuyama T, Ohuchi A, Ohnuma S, Sakamoto K, Sugai T, Katsumata K, Matsushita HO, Yamano HO, Eda H, Uraoka T, Akimoto N, Kobayashi H, Sugihara K, and Ueno H
- Subjects
- Humans, Male, Female, Aged, Japan, Middle Aged, Lymphatic Metastasis, Risk Factors, Neoplasm Invasiveness, Colectomy methods, Clinical Decision-Making, Reoperation statistics & numerical data, Adult, Aged, 80 and over, Disease-Free Survival, Margins of Excision, Treatment Outcome, East Asian People, Colorectal Neoplasms pathology, Colorectal Neoplasms surgery, Neoplasm Staging, Practice Guidelines as Topic, Neoplasm Recurrence, Local epidemiology
- Abstract
Introduction: To verify the value of the pathological criteria for additional treatment in locally resected pT1 colorectal carcinoma (CRC) which have been used in the Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines since 2009., Methods: We enrolled 4,667 patients with pT1 CRC treated at 27 institutions between July 2009 and December 2016 (1,257 patients with local resection alone [group A], 1,512 patients with additional surgery after local resection [group B], and 1,898 patients with surgery alone [group C]). All 5 factors of the JSCCR guidelines (submucosal resection margin, tumor histologic grade, submucosal invasion depth, lymphovascular invasion, and tumor budding) for lymph node metastasis (LNM) had been diagnosed prospectively., Results: Any of the risk factors were present in 3,751 patients. The LNM incidence was 10.4% (95% confidence interval 9.4-11.5) in group B/C patients with risk factors, whereas it was 1.8% (95% confidence interval 0.4-5.3) in those without risk factors ( P < 0.01). In group A, the incidence of recurrence was 3.6% in patients with risk factors, but it was only 0.4% in patients without risk factors ( P < 0.01). The disease-free survival rate of group A patients classified as risk positive was significantly worse than those of groups B and C patients. However, the 5-year disease-free survival rate in group A patients with no risk was 99.6%., Discussion: Our large-scale real-world multicenter study demonstrated the validity of the JSCCR criteria for pT1 CRC after local resection, especially regarding favorable outcomes in patients with low risk of LNM., (Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology.)
- Published
- 2024
- Full Text
- View/download PDF
31. Progresses Toward Polio Eradication in Asian Countries: Its History and Japan's Contributions.
- Author
-
Toizumi M, Takamatsu M, Toda K, and Horikoshi Y
- Subjects
- Humans, Japan epidemiology, History, 20th Century, Poliovirus Vaccine, Oral history, Poliovirus Vaccine, Oral administration & dosage, Poliovirus isolation & purification, History, 21st Century, Disease Outbreaks history, Disease Outbreaks prevention & control, Asia epidemiology, Poliovirus Vaccine, Inactivated history, Poliovirus Vaccine, Inactivated administration & dosage, Poliomyelitis prevention & control, Poliomyelitis history, Poliomyelitis epidemiology, Disease Eradication history
- Abstract
Japan experienced a large outbreak of wild poliovirus in the 1960s. The government made an exceptional decision to import oral polio vaccines (OPVs) from the Soviet Union and Canada while bypassing the usual approval process for medical products. Mass vaccination and subsequent, routine immunization successfully contained the wild poliovirus; the last case in Japan was reported in 1980. Domestic OPV had been used to sustain Japan's polio-free state. In 2012, the world's first inactivated polio vaccine developed from the Sabin vaccine replaced OPVs. Domestic vaccines combined with Sabin-derived inactivated polio vaccine are currently used in Japan. When the World Health Assembly announced the Global Polio Eradication Initiative in 1988, the Japanese government made a commitment to support endemic countries. The Japan International Cooperation Agency supported the establishment of microbiological laboratories, surveillance, distribution of polio vaccines and capacity building. Vaccine-derived poliovirus emerged as a new, international risk in the early 2000s. Vaccine-derived poliovirus was also detected in several Asian countries and required an outbreak response with additional vaccinations and strengthened surveillance. Genetically stable, novel, oral polio vaccine type 2 became available for use in outbreak responses and was used in Indonesia. Japan maintains its commitment to work toward the eradication of the poliovirus., Competing Interests: This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors. Y.H. is a principal investigator for COVID-19 vaccine trial of Shionogi Pharma. The other authors have no conflicts of interest to disclose., (Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
32. Efficacy of a whole slide image-based prediction model for lymph node metastasis in T1 colorectal cancer: A systematic review.
- Author
-
Ichimasa K, Kouyama Y, Kudo SE, Takashina Y, Nemoto T, Watanabe J, Takamatsu M, Maeda Y, Yeoh KG, Miyachi H, and Misawa M
- Abstract
Background and Aim: Accurate stratification of the risk of lymph node metastasis (LNM) following endoscopic resection of submucosal invasive (T1) colorectal cancer (CRC) is imperative for determining the necessity for additional surgery. In this systematic review, we evaluated the efficacy of prediction of LNM by artificial intelligence (AI) models utilizing whole slide image (WSI) in patients with T1 CRC., Methods: In accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, a systematic review was conducted through searches in PubMed (MEDLINE), Embase, and the Cochrane Library for relevant studies published up to December 2023. The inclusion criteria were studies assessing the accuracy of hematoxylin and eosin-stained WSI-based AI models for predicting LNM in patients with T1 CRC., Results: Four studies met the criteria for inclusion in this systematic review. The area under the receiver operating characteristic curve for these AI models ranged from 0.57 to 0.76. In the three studies in which AI performance was compared directly with current treatment guidelines, AI consistently exhibited a higher area under the receiver operating characteristic curve. At a fixed sensitivity of 100%, specificities ranged from 18.4% to 45.0%., Conclusions: Artificial intelligence models based on WSI can potentially address the issue of diagnostic variability between pathologists and exceed the predictive accuracy of current guidelines. However, these findings require confirmation by larger studies that incorporate external validation., (© 2024 The Author(s). Journal of Gastroenterology and Hepatology published by Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
33. Development and Validation Study of the Prognostic Impact of Deep Learning-Determined Myxoid Stroma After Neoadjuvant Chemotherapy in Patients with Esophageal Squamous Cell Carcinoma.
- Author
-
Kouzu K, Tsujimoto H, Imamura Y, Kajiwara Y, Nearchou IP, Einama T, Takamatsu M, Haraguchi I, Watanabe T, Horiguchi H, Kishi Y, Tsuda H, Watanabe M, and Ueno H
- Subjects
- Humans, Female, Male, Middle Aged, Survival Rate, Prognosis, Follow-Up Studies, Aged, Esophagectomy, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Retrospective Studies, Chemotherapy, Adjuvant, Stromal Cells pathology, Neoadjuvant Therapy mortality, Esophageal Neoplasms pathology, Esophageal Neoplasms drug therapy, Esophageal Neoplasms mortality, Esophageal Neoplasms surgery, Esophageal Neoplasms therapy, Esophageal Squamous Cell Carcinoma pathology, Esophageal Squamous Cell Carcinoma drug therapy, Esophageal Squamous Cell Carcinoma surgery, Esophageal Squamous Cell Carcinoma therapy, Deep Learning
- Abstract
Purpose: This study was designed to investigate the prognostic significance of artificial intelligence (AI)-based quantification of myxoid stroma in patients undergoing esophageal squamous cell carcinoma (ESCC) surgery after neoadjuvant chemotherapy (NAC) and to verify its significance in an independent validation cohort from another hospital., Methods: We evaluated two datasets of patients with pathological stage II or III ESCC who underwent surgery after NAC. Cohort 1 consisted of 85 patients who underwent R0 surgery for the primary tumor after NAC. Cohort 2, the validation cohort, consisted of 80 patients who received same treatments in another hospital. AI-based myxoid stroma was evaluated in resected specimens, and its area was categorized by using the receiver operating characteristic curve for overall survival (OS) of cohort 1., Results: The F1 scores, which are the degree of agreement between the automatically detected myxoid stroma and manual annotations, were 0.83 and 0.79 for cohorts 1 and 2. The myxoid stroma-high group had a significantly poorer prognosis than the myxoid stroma-low group in terms of OS, disease-specific survival (DSS), and recurrence-free survival (RFS) in cohort 1. Comparable results were observed in cohort 2, where OS, DSS, and RFS were significantly affected by myxoid stroma. Multivariate analysis for RFS revealed that AI-determined myxoid stroma-high was one of the independent prognostic factors in cohort 1 (hazard ratio [HR] 1.97, p = 0.037) and cohort 2 (HR 4.45, p < 0.001)., Conclusions: AI-determined myxoid stroma may be a novel and useful prognostic factor for patients with pathological stage II or III ESCC after NAC., (© 2024. Society of Surgical Oncology.)
- Published
- 2024
- Full Text
- View/download PDF
34. Correction to: Treatment Decision for Locally Resected T1 Colorectal Carcinoma-Verification of the Japanese Guideline Criteria for Additional Surgery Based on Long-Term Clinical Outcomes.
- Author
-
Oka S, Tanaka S, Kajiwara Y, Saito S, Fukunaga Y, Takamatsu M, Kawachi H, Hotta K, Ikematsu H, Kojima M, Saito Y, Yamada M, Kanemitsu Y, Sekine S, Nagata S, Yamada K, Kobayashi N, Ishihara S, Saitoh Y, Matsuda K, Togashi K, Komori K, Ishiguro M, Kuwai T, Okuyama T, Ohuchi A, Ohnuma S, Sakamoto K, Sugai T, Katsumata K, Matsushita HO, Yamano HO, Eda H, Uraoka T, Akimoto N, Kobayashi H, Sugihara K, and Ueno H
- Published
- 2024
- Full Text
- View/download PDF
35. Prognostic factors for patients 85 years or older undergoing endoscopic submucosal dissection for early gastric cancer.
- Author
-
Izumi A, Horiuchi Y, Takamatsu M, Fukuyama C, Yamamoto H, Namikawa K, Tokai Y, Yoshimizu S, Ishiyama A, Yoshio T, Hirasawa T, Fujisaki J, and Gotoda T
- Subjects
- Humans, Male, Female, Retrospective Studies, Aged, 80 and over, Prognosis, Survival Rate, Gastrectomy methods, Age Factors, Stomach Neoplasms surgery, Stomach Neoplasms pathology, Stomach Neoplasms mortality, Endoscopic Mucosal Resection methods
- Abstract
Background: Little is known about prognostic factors for patients 85 years or older undergoing endoscopic submucosal dissection for early gastric cancer. Therefore, this study aimed to identify such prognostic factors., Methods: We retrospectively evaluated the long-term outcomes and prognostic factors of 143 patients 85 years or older undergoing endoscopic submucosal dissection for early gastric cancer at a single-center between October 2005 and September 2020. Using the Kaplan-Meier method and a Cox proportional hazards regression model, we examined the relationships of patient characteristics and endoscopic curability (additional gastrectomy recommended [eCuraC-2] or not recommended) with overall survival., Results: The median age of the patients was 86 years, and most patients were men (65%). The eCuraC-2 rate was 14.7%. During the follow-up period, 55 patients died; however, only two patients died due to gastric cancer. The 3-year and 5-year overall survival rates were 91.5% and 74.7%, respectively. Male sex (hazard ratio, 2.23; 95% confidence interval, 1.16-4.30), American Society of Anesthesiologists Physical Status of 3 (hazard ratio, 2.57; 95% confidence interval, 1.32-4.99), body mass index < 18.9 kg/m
2 (hazard ratio, 2.21; 95% confidence interval, 1.11-4.40), and eCuraC-2 (hazard ratio, 3.04; 95% confidence interval, 1.37-6.75) were identified as independent prognostic factors. Moreover, patients with eCuraC-2 had significantly more poor prognostic factors than those who did not., Conclusions: The decision to perform endoscopic submucosal dissection for patients with the aforementioned prognostic factors should be carefully considered because follow-up without endoscopic submucosal dissection is possible., (© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)- Published
- 2024
- Full Text
- View/download PDF
36. Prediction of the invasion depth of superficial nonampullary duodenal adenocarcinoma.
- Author
-
Morita Y, Yoshimizu S, Takamatsu M, Kawachi H, Nakano K, Ikenoyama Y, Tokai Y, Namikawa K, Horiuchi Y, Ishiyama A, Yoshio T, Hirasawa T, and Fujisaki J
- Subjects
- Humans, Male, Female, Retrospective Studies, Aged, Middle Aged, Aged, 80 and over, Intestinal Mucosa pathology, Intestinal Mucosa diagnostic imaging, Adult, Neoplasm Staging, Biopsy, Adenocarcinoma pathology, Adenocarcinoma diagnostic imaging, Adenocarcinoma surgery, Neoplasm Invasiveness, Duodenal Neoplasms pathology, Duodenal Neoplasms diagnostic imaging, Duodenal Neoplasms surgery, Endosonography
- Abstract
Objectives: Distinguishing between intramucosal cancer and submucosal invasive cancer is vital for optimal treatment selection for patients with superficial nonampullary duodenal adenocarcinoma (SNADAC); however, standard diagnostic systems for diagnosing invasion depth are as yet undetermined., Methods: Of 205 patients with SNADAC who underwent treatment at our institution between 2006 and 2022, 188 had intramucosal cancer and 17 had submucosal invasive cancer. The clinical, endoscopic, and pathological features used in the preoperative diagnosis of invasion depth and the diagnostic performance of endoscopic ultrasonography (EUS) were retrospectively analyzed in 85 patients., Results: The oral side of the papilla tumor location, protruded or mixed macroscopic type, and moderately-to-poorly differentiated adenocarcinoma based on biopsy specimens were significantly more frequent in submucosal invasive cancer than in intramucosal cancer (88% vs. 48%; 94% vs. 42%; 47% vs. 0%, respectively). From the relationship between the endoscopic features and the submucosal invasive cancer incidence, submucosal invasion risk was stratified as: (i) low-risk (risk, 2%), all lesions located on the anal side of the papilla and superficial macroscopic type on the oral side of the papilla; and (ii) high-risk (risk, 23%), protruded or mixed macroscopic type on the oral side of the papilla. Based on the biopsy specimens, all eight patients with moderately-to-poorly differentiated adenocarcinoma had submucosal invasive cancer. Furthermore, EUS was not associated with invasion depth's diagnostic accuracy improvements., Conclusion: Optimal treatment indications for SNADAC can be selected based on the risk factors of submucosal invasion by tumor location, macroscopic type, and biopsy diagnosis., (© 2023 Japan Gastroenterological Endoscopy Society.)
- Published
- 2024
- Full Text
- View/download PDF
37. Characterization of double-negative T cells in colorectal cancers and their corresponding lymph nodes.
- Author
-
Okamura K, Wang L, Nagayama S, Yamashita M, Tate T, Matsumoto S, Takamatsu M, Kitano S, Kiyotani K, and Nakamura Y
- Subjects
- Humans, CD8-Positive T-Lymphocytes immunology, CD8-Positive T-Lymphocytes metabolism, Lymphocytes, Tumor-Infiltrating immunology, Lymphocytes, Tumor-Infiltrating metabolism, Male, Female, CD4-Positive T-Lymphocytes immunology, CD4-Positive T-Lymphocytes metabolism, Aged, Receptors, Antigen, T-Cell metabolism, Receptors, Antigen, T-Cell genetics, T-Lymphocyte Subsets immunology, T-Lymphocyte Subsets metabolism, Middle Aged, Colorectal Neoplasms immunology, Colorectal Neoplasms pathology, Lymph Nodes immunology, Lymph Nodes pathology, Tumor Microenvironment immunology
- Abstract
TCRαβ+ CD4- CD8- double-negative T (DNT) cells are minor populations in peripheral blood, and their roles have mostly been discussed in inflammation and autoimmunity. However, the functions of DNT cells in tumor microenvironment remain to be elucidated. We investigated their characteristics, possible origins and functions in colorectal cancer tissues as well as their corresponding tumor-draining lymph nodes. We found a significant enrichment of DNT cells in tumor tissues compared with their corresponding lymph nodes, especially in tumors with lower T cell infiltration. T cell receptor (TCR) sequence analysis of CD4+ T, CD8+ T and DNT cells indicated that TCR sequences detected in DNT cells were found in CD8+ T cells, but rarely in CD4+ T cells, suggesting that a part of DNT cells was likely to be originated from CD8+ T cells. Through a single-cell transcriptomic analysis of DNT cells, we found that a DNT cell cluster, which showed similar phenotypes to central memory CD8+ T cells with low expression of effector and exhaustion markers, revealed some specific gene expression patterns, including higher GZMK expression. Moreover, in flow cytometry analysis, we found that DNT cells lost production of cytotoxic mediators. These findings imply that DNT cells might function as negative regulators of anti-tumor immune responses in tumor microenvironment., Competing Interests: KK is a scientific advisor of Cancer Precision Medicine, Inc. YN is a stockholder and a scientific advisor of OncoTherapy Science, Inc., (© 2024 The Author(s). Published with license by Taylor & Francis Group, LLC.)
- Published
- 2024
- Full Text
- View/download PDF
38. Risk stratification for synchronous/metachronous recurrence after endoscopic submucosal dissection for Barrett's esophageal adenocarcinoma using the length of Barrett's esophagus.
- Author
-
Ikenoyama Y, Namikawa K, Takamatsu M, Kumazawa Y, Tokai Y, Yoshimizu S, Horiuchi Y, Ishiyama A, Yoshio T, Hirasawa T, Ogura T, and Fujisaki J
- Subjects
- Humans, Male, Female, Aged, Retrospective Studies, Middle Aged, Risk Assessment methods, Risk Factors, Japan epidemiology, Incidence, Neoplasms, Second Primary epidemiology, Esophagoscopy methods, Neoplasms, Multiple Primary surgery, Neoplasms, Multiple Primary pathology, Aged, 80 and over, Barrett Esophagus surgery, Barrett Esophagus pathology, Esophageal Neoplasms surgery, Esophageal Neoplasms pathology, Endoscopic Mucosal Resection methods, Adenocarcinoma surgery, Adenocarcinoma pathology, Neoplasm Recurrence, Local epidemiology
- Abstract
Background: In Japan, the standard management of Barrett's esophageal adenocarcinoma after endoscopic submucosal dissection involves follow-up; however, multifocal synchronous/metachronous lesions are sometimes observed after endoscopic submucosal dissection. Risk stratification of multifocal cancer facilitates appropriate treatment, including eradication of Barrett's esophagus in high-risk cases; however, no effective risk stratification methods have been established. Thus, we identified the risk factors for multifocal cancer and explored risk-stratified treatment strategies for residual Barrett's esophagus., Methods: We retrospectively reviewed the data of 97 consecutive patients with superficial Barrett's esophageal adenocarcinomas who underwent curative resection with endoscopic submucosal dissection. Multifocal cancer was defined by the presence of synchronous/metachronous lesions during follow-up. We used Cox regression analysis to identify the risk factors for multifocal cancer and subsequently analyzed differences in cumulative incidences., Results: The cumulative incidences of multifocal cancer at 1, 3, and 5 years were 4.4%, 8.6%, and 10.7%, respectively. Significant risk factors for multifocal cancer were increased circumferential and maximal lengths of Barrett's esophagus. The cumulative incidences of multifocal cancer at 3 years were lower for patients with circumferential length < 4 cm and maximal length < 5 cm (2.9% and 1.2%, respectively) than for patients with circumferential length ≥ 4 cm and maximal length ≥ 5 cm (51.5% and 49.1%, respectively)., Conclusions: Risk stratification of multifocal cancer using length of Barrett's esophagus was effective. Further multicenter prospective studies are needed to substantiate our findings., (© 2024. The Author(s), under exclusive licence to The Author(s) under exclusive licence to The Japan Esophageal Society.)
- Published
- 2024
- Full Text
- View/download PDF
39. Long- vs short-segment Barrett's esophagus-derived adenocarcinoma: clinical features and outcomes of endoscopic submucosal dissection.
- Author
-
Ikenoyama Y, Namikawa K, Takamatsu M, Kumazawa Y, Tokai Y, Yoshimizu S, Horiuchi Y, Ishiyama A, Yoshio T, Hirasawa T, and Fujisaki J
- Subjects
- Humans, Male, Female, Retrospective Studies, Aged, Middle Aged, Treatment Outcome, Esophagoscopy methods, Barrett Esophagus surgery, Barrett Esophagus pathology, Endoscopic Mucosal Resection methods, Adenocarcinoma surgery, Adenocarcinoma pathology, Esophageal Neoplasms pathology, Esophageal Neoplasms surgery
- Abstract
Background: The incidence of Barrett's esophageal adenocarcinoma (BEA) is increasing, and endoscopic submucosal dissection (ESD) has been frequently performed for its treatment. However, the differences between the characteristics and ESD outcomes between short- and long-segment BEA (SSBEA and LSBEA, respectively) are unclear. We compared the clinicopathological characteristics and short- and long-term outcomes of ESD between both groups., Methods: We retrospectively reviewed 155 superficial BEAs (106 SSBEAs and 49 LSBEAs) treated with ESD in 139 patients and examined their clinicopathological features and ESD outcomes. SSBEA and LSBEA were classified based on whether the maximum length of the background mucosa of BEA was < 3 cm or ≥ 3 cm, respectively., Results: Compared with SSBEA, LSBEA showed significantly higher proportions of cases with the macroscopically flat type (36.7% vs. 5.7%, p < 0.001), left wall location (38.8% vs. 11.3%, p < 0.001), over half of the tumor circumference (20.4% vs. 1.9%, p < 0.001), and synchronous lesions (17.6% vs. 0%, p < 0.001). Compared with SSBEA, regarding ESD outcomes, LSBEA showed significantly longer resection duration (91.0 min vs. 60.5 min, p < 0.001); a lower proportion of submucosal invasion (14.3% vs. 29.2%, p = 0.047), horizontal margin negativity (79.6% vs. 94.3%, p = 0.0089), and R0 resection (69.4% vs. 86.8%, p = 0.024); and a higher proportion of post-procedural stenosis cases (10.9% vs. 1.9%, p = 0.027). The 5-year cumulative incidence of metachronous cancer in patients without additional treatment was significantly higher for LSBEA than for SSBEA (25.0% vs. 0%, p < 0.001)., Conclusions: The clinicopathological features of LSBEA and SSBEA and their treatment outcomes differed in many aspects. As LSBEAs are difficult to diagnose and treat and show a high risk of metachronous cancer development, careful ESD and follow-up or eradication of the remaining BE may be required., (© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
40. Early gastric cancer with RhoGAP fusion is linked to frequent nodal metastasis and a part of microtubular-mucocellular histology.
- Author
-
Noda H, Sakata S, Baba S, Togashi Y, Nakano K, Hirasawa T, Nakayama I, Hata C, Takamatsu M, Sugawara E, Yamamoto N, Fujisaki J, Nunobe S, Iwakiri K, Takeuchi K, and Kawachi H
- Subjects
- Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Biomarkers, Tumor genetics, Oncogene Proteins, Fusion genetics, Prognosis, GTPase-Activating Proteins genetics, Lymphatic Metastasis pathology, Lymphatic Metastasis genetics, Stomach Neoplasms pathology, Stomach Neoplasms genetics
- Abstract
Introduction: Gastric cancer with fusion genes involving the Rho GTPase-activating protein domain (RhoGAP-GC) is mainly included in the genomically stable type of The Cancer Genome Atlas classification. Clinical implications and histological characteristics of RhoGAP-GC in the early phase remain unclear., Methods: We analyzed 878 consecutive pT1b GCs for RhoGAP and its partner genes using fluorescence in situ hybridization assay., Results: RhoGAP fusion was detected in 57 (6.5%) GCs. Univariate analysis revealed that female sex, middle-lower third tumor location, advanced macroscopic type, tumor diameter > 2 cm, pT1b2, lymphatic invasion, venous invasion, negative EBER-ISH, and RhoGAP fusion were significantly associated with lymph node metastasis (LNM). Multivariate analysis presented RhoGAP fusion, lymphatic invasion, tumor diameter > 2 cm, advanced macroscopic type, venous invasion, and middle-lower third tumor location as independent risk factors for LNM. Notably, RhoGAP fusion had the highest odds ratio (3.92) for LNM among analyzed parameters (95% CI 2.12-7.27; p < 0.001). Compared to non-RhoGAP-GCs, RhoGAP-GCs were significantly frequent in younger females and showed the highest incidence of lymphatic invasion (56.2%) and LNM (49.1%) (p < 0.001). Histologically, microtubular architecture with pseudo-trabecular interconnection and small aggregations of tumor cells with a varied amount of cytoplasmic mucin, named "microtubular-mucocellular (MTMC) histology," was found in 93.0% (53 of 57) of RhoGAP-GCs in the intramucosal area. MTMC histology showed high sensitivity and negative predictive value (93.0% and 99.4%, respectively) for RhoGAP fusion, albeit positive predictive value is low (34.9%)., Conclusion: RhoGAP-GC is linked to a characteristic MTMC histology and a high incidence of LNM., (© 2024. The Author(s) under exclusive licence to The International Gastric Cancer Association and The Japanese Gastric Cancer Association.)
- Published
- 2024
- Full Text
- View/download PDF
41. Long-Term Outcomes of Additional Surgery After Endoscopic Resection Versus Primary Surgery for T1 Colorectal Cancer.
- Author
-
Tamaru Y, Kuwai T, Kajiwara Y, Oka S, Saito S, Fukunaga Y, Kawachi H, Takamatsu M, Hotta K, Ikematsu H, Kojima M, Saito Y, Kanemitsu Y, Yamada M, Sekine S, Tanaka S, Nagata S, Nakamura T, Yamada K, Konno M, Ishihara S, Saitoh Y, Matsuda K, Togashi K, Komori K, Ishiguro M, Okuyama T, Ohuchi A, Ohnuma S, Sakamoto K, Sugai T, Katsumata K, Matsushita HO, Yamano HO, Nakai K, Uraoka T, Akimoto N, Kobayashi H, Ajioka Y, Sugihara K, and Ueno H
- Abstract
Introduction: There is considerable concern about whether endoscopic resection (ER) before additional surgery (AS) for T1 colorectal cancer (CRC) has oncologically potential adverse effects. Therefore, the aim of this study was to compare the long-term outcomes, including overall survival (OS), of patients treated with AS after ER vs primary surgery (PS) for T1 CRC using a propensity score-matched analysis from a large observational study., Methods: This study investigated 6,105 patients with T1 CRC treated with either ER or surgical resection between 2009 and 2016 at 27 high-volume Japanese institutions, with those undergoing surgery alone included in the PS group and those undergoing AS after ER included in the AS group. Propensity score matching was used for long-term outcomes of mortality and recurrence analysis., Results: After propensity score matching, 1,219 of 2,438 patients were identified in each group. The 5-year OS rates in the AS and PS groups were 97.1% and 96.0%, respectively (hazard ratio: 0.72, 95% confidence interval: 0.49-1.08), indicating the noninferiority of the AS group. Moreover, 32 patients (2.6%) in the AS group and 24 (2.0%) in the PS group had recurrences, with no significant difference between the 2 groups (odds ratio: 1.34, 95% confidence interval: 0.76-2.40, P = 0.344)., Discussion: ER before AS for T1 CRC had no adverse effect on patients' long-term outcomes, including the 5-year OS rate. ER is a viable first-line treatment option for endoscopically resectable T1 CRC., (Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology.)
- Published
- 2024
- Full Text
- View/download PDF
42. Low incidence of pancreatic fistula and well-preserved endocrine function with non-reconstructed small remnant pancreas after pancreaticoduodenectomy.
- Author
-
Miyashita M, Yoshioka R, Fukumura Y, Takamatsu M, Oba A, Ono Y, Inoue Y, Mise Y, Takahashi Y, and Saiura A
- Abstract
Aim: Pancreatic reconstruction after pancreaticoduodenectomy (PD) that leaves a small remnant pancreas is often difficult. Pancreatic fistula is a major complication after PD, and fistulas are rare in patients with hard pancreas. However, the clinical impact of non-reconstructed small remnant after PD with hard pancreas is unknown., Methods: We included all patients who underwent PD for pancreatic tumor without pancreatic reconstruction in two institutions supervised by one surgeon between January 2004 and March 2021. Their short- or long-term outcome after surgery was retrospectively analyzed., Results: PD was performed in 774 patients, of whom 16 patients were without reconstruction (2.1%) with negative margins at the pancreatic stump. Pancreatic transection was performed above or to the left of the superior mesenteric artery, with a median remnant pancreas length of 3.7 cm (range, 1.3-10.0). A major complication (≥ Clavien-Dindo Grade IIIa) occurred in one patient (6%). Fistula of grade B occurred in one patient (6%). After a median follow-up of 44 months (95%CI, 10.6-77.3), insulin administration was unnecessary in 11 patients., Conclusion: The preservation of a small pancreatic remnant without reconstruction after PD can be performed safely and may enable the keeping of pancreatic endocrine function for some selected patients with hard pancreas., Competing Interests: Akio Saiura, one of the co‐authors, is an editorial board member of Annals of Gastroenterological Surgery., (© 2024 The Authors. Annals of Gastroenterological Surgery published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Gastroenterological Surgery.)
- Published
- 2024
- Full Text
- View/download PDF
43. Prognostic factors of para-aortic lymph node metastasis from colorectal cancer in highly selected patients undergoing para-aortic lymph node dissection.
- Author
-
Emoto S, Fukunaga Y, Takamatsu M, Kawachi H, Sano S, Tominaga T, Mukai T, Yamaguchi T, Nagasaki T, Akiyoshi T, Konishi T, Nagayama S, and Ueno M
- Subjects
- Humans, Prognosis, Lymphatic Metastasis pathology, Retrospective Studies, Lymph Nodes pathology, Lymph Node Excision, Rectal Neoplasms surgery, Rectal Neoplasms pathology
- Abstract
Purpose: We investigated the surgical outcomes of para-aortic lymph node (PALN) dissection in patients with colorectal cancer and assessed the prognostic factors related to the survival., Methods: This single-center retrospective study included 31 patients with synchronous or metachronous PALN metastasis from colorectal cancer who underwent PALN dissection between January 2006 and December 2018., Results: Twenty-one patients had synchronous PALN metastasis, and 10 had metachronous PALN metastasis. Seven patients had either simultaneous distant metastasis or a history of distant metastasis other than PALN metastasis at the time of PALN dissection. Eighteen patients underwent adjuvant chemotherapy. The 5-year overall and recurrence-free survival rates were 54.2 and 17.2%, respectively. A multivariable analysis revealed that rectal cancer, metachronous PALN metastasis, and three or more pathological PALN metastases were significantly poor prognostic factors for the recurrence-free survival. Among patients with rectal cancer, lower rectal cancer and lateral pelvic lymph node metastasis were poor prognostic factors for the overall survival., Conclusion: Curative PALN dissection for PALN metastasis from colorectal cancer is feasible with favorable long-term outcomes. A multidisciplinary approach, including surgery and chemotherapy, is needed for colorectal cancer with PALN metastasis to improve the long-term outcomes., (© 2023. The Author(s) under exclusive licence to Springer Nature Singapore Pte Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
44. APC/PIK3CA mutations and β-catenin status predict tankyrase inhibitor sensitivity of patient-derived colorectal cancer cells.
- Author
-
Chen M, Mashima T, Oishi T, Muramatsu Y, Seto Y, Takamatsu M, Kawata N, Morino S, Nakamura A, Inaba S, Yuan X, Maruyama K, Suzuki M, Sato A, Yoshida H, Jang MK, Mizutani A, Takeuchi K, Yamaguchi K, Shirai F, Nagayama S, Katayama R, and Seimiya H
- Subjects
- Animals, Mice, Humans, Cell Line, Tumor, beta Catenin genetics, beta Catenin metabolism, Mice, Inbred NOD, Wnt Signaling Pathway genetics, Biomarkers, Class I Phosphatidylinositol 3-Kinases genetics, Class I Phosphatidylinositol 3-Kinases metabolism, Colorectal Neoplasms drug therapy, Colorectal Neoplasms genetics, Colorectal Neoplasms metabolism, Tankyrases genetics, Tankyrases metabolism
- Abstract
Background: Aberrant WNT/β-catenin signaling drives carcinogenesis. Tankyrases poly(ADP-ribosyl)ate and destabilize AXINs, β-catenin repressors. Tankyrase inhibitors block WNT/β-catenin signaling and colorectal cancer (CRC) growth. We previously reported that 'short' APC mutations, lacking all seven β-catenin-binding 20-amino acid repeats (20-AARs), are potential predictive biomarkers for CRC cell sensitivity to tankyrase inhibitors. Meanwhile, 'Long' APC mutations, which possess more than one 20-AAR, do not predict inhibitor-resistant cells. Thus, additional biomarkers are needed to precisely predict the inhibitor sensitivity., Methods: Using 47 CRC patient-derived cells (PDCs), we examined correlations between the sensitivity to tankyrase inhibitors (G007-LK and RK-582), driver mutations, and the expressions of signaling factors. NOD.CB17-Prkdc
scid /J and BALB/c-nu/nu xenograft mice were treated with RK-582., Results: Short APC mutant CRC cells exhibited high/intermediate sensitivities to tankyrase inhibitors in vitro and in vivo. Active β-catenin levels correlated with inhibitor sensitivity in both short and long APC mutant PDCs. PIK3CA mutations, but not KRAS/BRAF mutations, were more frequent in inhibitor-resistant PDCs. Some wild-type APC PDCs showed inhibitor sensitivity in a β-catenin-independent manner., Conclusions: APC/PIK3CA mutations and β-catenin predict the sensitivity of APC-mutated CRC PDCs to tankyrase inhibitors. These observations may help inform the strategy of patient selection in future clinical trials of tankyrase inhibitors., (© 2023. The Author(s), under exclusive licence to Springer Nature Limited.)- Published
- 2024
- Full Text
- View/download PDF
45. Unique Biology of Pancreatic Ductal Adenocarcinoma Accompanied by Rapidly Impaired Diabetes: A Favorable Long-Term Survival Following Curative Resection.
- Author
-
Kiritani S, Ono Y, Takamatsu M, Yoshio S, Miyashita M, Oba A, Sato T, Ito H, Inoue Y, Saiura A, and Takahashi Y
- Subjects
- Humans, Retrospective Studies, Pancreatectomy, Biology, Survival Rate, Prognosis, Carcinoma, Pancreatic Ductal complications, Carcinoma, Pancreatic Ductal surgery, Pancreatic Neoplasms pathology, Diabetes Mellitus surgery
- Abstract
Background: Pancreatic ductal adenocarcinomas (PDACs) are sometimes diagnosed accompanied by rapidly impaired diabetes (PDAC-RID). Although this type of PDAC may have unusual biological features, these features have not been explained., Methods: Patients with PDAC who underwent upfront pancreatectomy between 2010 and 2018 were retrospectively reviewed. PDAC-RID was defined as a glycated hemoglobin (HbA1c) value of ≥ 8.0% of newly diagnosed diabetes, and acute exacerbation of previously diagnosed diabetes. Other patients were classified as PDAC with stable glycometabolism (PDAC-SG). Clinicopathological factors, long-term survival rates, and recurrence patterns were evaluated., Results: Of the 520 enrolled patients, 104 were classified as PDAC-RID and 416 as PDAC-SG. There was no significant difference regarding TNM staging, resectability, or adjuvant chemotherapy rate between the groups. However, 5-years cancer-specific survival (CSS) was significantly higher in the PDAC-RID group than in the PDAC-SG group (45.3% vs. 31.1%; p = 0.02). This survival difference was highlighted in relatively early-stage PDAC (≤ pT2N1) (CSS: 60.8% vs. 43.6%; p = 0.01), but the difference was not significant for advanced-stage PDAC. A multivariate analysis of early-stage PDAC showed that PDAC-SG was an independent risk factor of shorter CSS (hazard ratio 1.76; p = 0.02). The hematogenous metastatic rate in early-stage PDAC was lower in the PDAC-RID group than in the PDAC-SG group (18.3% vs. 35.8%; p = 0.01)., Conclusions: PDAC-RID showed a favorable long-term survival rate after curative resection with low hematogenous metastases, which may be due to its unique biology., (© 2023. Society of Surgical Oncology.)
- Published
- 2024
- Full Text
- View/download PDF
46. New approach of circumferential lymph node dissection around the superior mesenteric artery for pancreatic cancer during pancreaticoduodenectomy (with video).
- Author
-
Ono Y, Inoue Y, Kato T, Kobayashi K, Takamatsu M, Atsushi O, Sato T, Ito H, and Takahashi Y
- Subjects
- Humans, Mesenteric Artery, Superior surgery, Mesenteric Artery, Superior pathology, Lymph Node Excision methods, Pancreaticoduodenectomy methods, Pancreatic Neoplasms pathology
- Abstract
Purpose: Various approaches have been reported for the resection of the nervous and lymphatic tissues around the superior mesenteric artery (SMA) during pancreaticoduodenectomy (PD) for pancreatic cancer. We developed a new procedure for circumferential lymph node dissection around the SMA to minimize local recurrence., Methods: We included 24 patients who underwent PD with circumferential lymph node dissection around the SMA (circumferential dissection) and 94 patients who underwent classical mesopancreatic dissection (classical dissection) between 2019 and 2021. The technical details of this new method are described in the figures and videos, and the clinical characteristics and outcomes of this technique were compared with those of classical dissection., Results: The median follow-up durations in the circumferential and classical dissection groups were 39 and 36 months, respectively. The patients' characteristics, including tumor resectability, preoperative and adjuvant chemotherapy rates, postoperative complication rates, and tumor stage, were similar between the two groups. No differences were observed in recurrence-free survival and overall survival between the two groups; however, the classical dissection group tended to have more local recurrences than the circumferential dissection group (8.3% vs. 33.3%, P = 0.168). Although no case of nodular-type recurrence after circumferential dissection was observed, 61.1% of local recurrences after classical dissection were of the nodular-type, and 36.4% were located on the left side of the SMA., Conclusions: Performing circumferential lymph node dissection around the SMA during PD can be conducted safely with minimal risks of local recurrence and may enhance the completeness of local resection., (© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
47. Post-operative mortality and recurrence patterns in pancreatic cancer according to KRAS mutation and CDKN2A, p53, and SMAD4 expression.
- Author
-
Masugi Y, Takamatsu M, Tanaka M, Hara K, Inoue Y, Hamada T, Suzuki T, Arita J, Hirose Y, Kawaguchi Y, Nakai Y, Oba A, Sasahira N, Shimane G, Takeda T, Tateishi K, Uemura S, Fujishiro M, Hasegawa K, Kitago M, Takahashi Y, Ushiku T, Takeuchi K, and Sakamoto M
- Subjects
- Humans, Tumor Suppressor Protein p53 genetics, Tumor Suppressor Protein p53 metabolism, Proto-Oncogene Proteins p21(ras) genetics, Mutation, Smad4 Protein genetics, Smad4 Protein metabolism, Cyclin-Dependent Kinase Inhibitor p16 metabolism, Pancreatic Neoplasms, Pancreatic Neoplasms genetics, Pancreatic Neoplasms pathology, Carcinoma
- Abstract
Alterations in KRAS, CDKN2A (p16), TP53, and SMAD4 genes have been major drivers of pancreatic carcinogenesis. The clinical course of patients with pancreatic cancer in relation to these driver alterations has not been fully characterised in large populations. We hypothesised that pancreatic carcinomas with different combinations of KRAS mutation and aberrant expression of CDKN2A, p53, and SMAD4 might show distinctive recurrence patterns and post-operative survival outcomes. To test this hypothesis, we utilised a multi-institutional cohort of 1,146 resected pancreatic carcinomas and assessed KRAS mutations by droplet digital polymerase chain reaction and CDKN2A, p53, and SMAD4 expression by immunohistochemistry. Multivariable hazard ratios (HRs) and 95% confidence intervals (CIs) for disease-free survival (DFS) and overall survival (OS) were computed according to each molecular alteration and the number of altered genes using the Cox regression models. Multivariable competing risks regression analyses were conducted to assess the associations of the number of altered genes with specific patterns of recurrence. Loss of SMAD4 expression was associated with short DFS (multivariable HR, 1.24; 95% CI, 1.09-1.43) and OS times (multivariable HR, 1.27; 95% CI, 1.10-1.46). Compared to cases with 0-2 altered genes, cases with three and four altered genes had multivariable HRs for OS of 1.28 (95% CI, 1.09-1.51) and 1.47 (95% CI, 1.22-1.78), respectively (p
trend < 0.001). Patients with an increasing number of altered genes were more likely to have short DFS time (ptrend = 0.003) and to develop liver metastasis (ptrend = 0.006) rather than recurrence at local or other distant sites. In conclusion, loss of SMAD4 expression and an increasing number of altered genes were associated with unfavourable outcomes in pancreatic cancer patients. This study suggests that the accumulation of the four major driver alterations can confer a high metastatic potential to the liver, thereby impairing post-operative survival among patients with pancreatic cancer., (© 2023 The Authors. The Journal of Pathology: Clinical Research published by The Pathological Society of Great Britain and Ireland and John Wiley & Sons Ltd.)- Published
- 2023
- Full Text
- View/download PDF
48. Gastric succinate dehydrogenase-deficient gastrointestinal stromal tumor presenting as a solitary cystic lesion.
- Author
-
Hashimoto H, Miura S, Tanaka M, Sakuma J, Fujita Y, Takamatsu M, Noie T, and Morikawa T
- Subjects
- Humans, Succinate Dehydrogenase genetics, Mutation, Gastrointestinal Stromal Tumors diagnosis, Gastrointestinal Stromal Tumors pathology, Stomach Neoplasms diagnosis, Stomach Neoplasms pathology
- Published
- 2023
- Full Text
- View/download PDF
49. Risk Factors for Lymph Node Metastasis of Rectal Neuroendocrine Tumor and Its Prognostic Impact: A Single-Center Retrospective Analysis of 195 Cases with Radical Resection.
- Author
-
Hiyoshi Y, Daitoku N, Mukai T, Nagasaki T, Yamaguchi T, Akiyoshi T, Yasue C, Chino A, Saito S, Takamatsu M, and Fukunaga Y
- Subjects
- Humans, Prognosis, Retrospective Studies, Lymphatic Metastasis pathology, Lymph Node Excision methods, Risk Factors, Lymph Nodes surgery, Lymph Nodes pathology, Neuroendocrine Tumors pathology, Rectal Neoplasms surgery, Rectal Neoplasms pathology
- Abstract
Purpose: The incidence of rectal neuroendocrine tumors (NETs) has been steadily increasing. The risk factors for and prognostic impact of lymph node (LN) metastasis were analyzed in 195 patients with stage I-III rectal NET who underwent radical surgery., Methods: This retrospective, single-center study analyzed risk factors for LN metastasis focusing on previously identified factors and a novel risk factor: multiple rectal NETs. The association between LN metastasis and the prognosis was also analyzed., Results: Pathologically, the LN metastasis rate (also the rate of stage III disease) was 39%, which was higher than the clinical LN metastasis rate of 14%. Tumor size > 10 mm, presence of central depression, tumor grade G2, depth of invasion, LN swelling on preoperative imaging (cN1), venous invasion and multiple NETs were identified as risk factors for LN metastasis. As the tumor size and risk factors increased, the rate of LN metastasis increased. Among these 7 factors, venous invasion, cN1, and multiple NETs were identified as independent predictors of LN metastasis. LN metastasis of rectal NETs was associated with significantly poor disease-free and disease-specific survival., Conclusions: As risk factors increase, the potential for rectal NETs to metastasize to the LNs increases and LN metastasis is associated with a poor prognosis. This is the first study to report multiple NETs as a risk factor for LN metastasis. A future study examining the survival benefit of radical surgery accompanying LN dissection compared with local resection is warranted., (© 2023. Society of Surgical Oncology.)
- Published
- 2023
- Full Text
- View/download PDF
50. Clinicopathological study of surgically treated non-neoplastic diseases of the pancreas with special reference to autoimmune pancreatitis.
- Author
-
Seki M, Ninomiya E, Saiura A, Takahashi Y, Inoue Y, Katori M, Yamamoto N, Takamatsu M, Kato Y, Yamada K, Matsueda K, and Ohkura Y
- Subjects
- Humans, Retrospective Studies, Pancreas surgery, Immunoglobulin G, Autoimmune Pancreatitis surgery, Autoimmune Pancreatitis pathology, Autoimmune Diseases diagnosis, Autoimmune Diseases surgery, Pancreatic Neoplasms pathology, Pancreatitis, Chronic surgery
- Abstract
Purpose: After the popularization of serum immunoglobulin G4 (IgG4) measurement and endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) in our institute, surgical resection for non-neoplastic diseases of the pancreas became less common. Although the incidence of such false-positive cases was clarified in the 10-year period after the introduction of these measures (2009-2018), these data were not compared with the 30 years before 2009 (1979-2008). This study was performed to determine the percentage of autoimmune pancreatitis (AIP) that was included during the latter period and how the numbers of false-positive cases differed between the two periods., Methods: From 1979 to 2008, 51 patients had clinical suspicion of pancreatic carcinoma (false-positive disease). Among these 51 patients, 32 non-alcoholic patients who had tumor-forming chronic pancreatitis (TFCP) were clinically, histologically, and immunohistochemically compared with 11 patients who had TFCP during the latter 10-year period., Results: Retrospective IgG4 immunostaining of false-positive TFCP revealed 14 (35.0%) cases of AIP in the former 30 years versus 5 (45.5%) in the latter 10 years. There were 40 (5.9%) cases of TFCP among 675 patients in the former 30 years and 11 (0.9%) among 1289 patients in the latter 10 years., Conclusions: When the TFCP ratio of pancreatic resections and the AIP ratio of false-positive TFCPs were compared between the two periods, the TFCP ratio was 5.9% versus 0.9% and the AIP ratio was 35.0% versus 45.5%, respectively. It can thus be speculated that IgG4 measurement and EUS-FNA are absolutely imperative for the diagnosis of TFCP., (© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.